Table 2.

Multivariate analysis for recurrence-free survival in patients with grade 1–2, stage I–II endometrioid endometrial cancer (n=125)^a.

Variable	Hazard Ratio	95% CI	p-value
Age at diagnosis	1.07	1.03–1.10	< 0.001
BMI	1.00	0.96–1.03	0.83
Myometrial invasion ≥ 50%	0.80	0.35–1.83	0.59
LVSI	1.84	0.84–4.03	0.13
Tumor size	0.95	0.80–1.11	0.50
Adjuvant treatmentb	0.80	0.37–1.72	0.80
TP53 mutation	4.07	1.57–10.54	0.004
CTNNB1 mutation	5.97	2.69–13.21	<0.001

^a125 patients had the above information available and were included in the analysis

^bAdjuvant treatment was treated as a time-dependent covariate